Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

CAB Payments receives approval to operate representative office in New York

(Sharecast News) - Payment processing and FX business CAB Payments said on Wednesday that its Crown Agents Bank subsidiary has received approvals from the Board of Governors of the Federal Reserve System and the New York State Department of Financial Services to operate a representative office in New York. CAB Payments said the New York representative office will act as a regional business hub for CAB, enabling it to continue to serve its existing clients while driving new client business in the region.

The London-listed group highlighted that its licensed presence in the United States would also help it to build stronger relationships with US Dollar clearing partners and to further support FX and payment flows from clients across South and Central America.

Chief executive Neeraj Kapur said: "This presence in one of the world's leading financial centres further enhances our network, allowing us to better serve existing and new clients. With on-the-ground presence in the UK, Europe and now the US, we are creating a business with global reach.

"We are excited to bring our best-in-class FX and cross-border payment services to the Americas, helping businesses overcome the complexities of operating in hard-to-reach markets."

As of 0950 BST, CAB Payments shares were up 8.92% at 44.93p.

Reporting by Iain Gilbert at Sharecast.com

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.